These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3241367)

  • 1. [Obesity as a risk factor in hepatobiliary diseases].
    Oguma M; Harada T
    Nihon Rinsho; 1988 Nov; 46(11):2443-7. PubMed ID: 3241367
    [No Abstract]   [Full Text] [Related]  

  • 2. The natural history of nonalcoholic fatty liver disease: insights from children and mice.
    Ahima RS
    Gastroenterology; 2008 Dec; 135(6):1860-2. PubMed ID: 19000676
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatobiliary effects of obesity and weight-reducing surgery.
    Faloon WW
    Semin Liver Dis; 1988 Aug; 8(3):229-36. PubMed ID: 3068808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obesity and chronic complications of diabetes mellitus].
    Oikawa S; Sasaki A; Toyota T
    Nihon Rinsho; 1991 Feb; 49 Suppl():75-82. PubMed ID: 2033873
    [No Abstract]   [Full Text] [Related]  

  • 5. [Research on the relationship between non-alcoholic fatty liver disease and platelet phospholipid fatty acids].
    Yu XM; Li D; Xie HB; Wang Q; Xu AM; Bi QH; Ye XW; Fan FH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):225-6. PubMed ID: 19335990
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiopathology of lipid metabolism and liver changes in obesity].
    Cotrozzi G; Relli P; Cersosimo R; Venturi M; Rossi M
    Clin Ter; 1995; 146(8-9):483-90. PubMed ID: 8536431
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced plasma adiponectin in NASH: central obesity as an underestimated causative risk factor.
    Tietge UJ; Schmidt HH; Schütz T; Dippe P; Lochs H; Pirlich M
    Hepatology; 2005 Feb; 41(2):401; author reply 401-2. PubMed ID: 15660429
    [No Abstract]   [Full Text] [Related]  

  • 9. Obesity: a cause of steatohepatitis in children.
    Koçak N; Yüce A; Gürakan F; Ozen H
    Am J Gastroenterol; 2000 Apr; 95(4):1099-100. PubMed ID: 10763980
    [No Abstract]   [Full Text] [Related]  

  • 10. [Incidence of cholelithiasis in autopsy material and analysis of the composition of calculi].
    Marinovic I; Guerra C; Larach G
    Rev Med Chil; 1972 Nov; 100(11):1320-7. PubMed ID: 4658362
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the development of cholelithiasis in man (second of two parts).
    Bennion LJ; Grundy SM
    N Engl J Med; 1978 Nov; 299(22):1221-7. PubMed ID: 362198
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.
    Fishbein MH; Mogren C; Gleason T; Stevens WR
    J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):83-8. PubMed ID: 16385259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies in nonalcoholic fatty liver disorders.
    Poordad FF
    Expert Opin Emerg Drugs; 2005 May; 10(2):237-9. PubMed ID: 15934865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NASH in children].
    Ida S; Yoshimura N
    Nihon Rinsho; 2006 Jun; 64(6):1168-72. PubMed ID: 16768127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Widhalm K; Ghods E
    Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty metamorphosis of the liver in morbid obesity.
    Kern WH; Heger AH; Payne JH; DeWind LT
    Arch Pathol; 1973 Nov; 96(5):342-6. PubMed ID: 4741905
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fatty liver and obesity].
    Kucio C; Waluga M; Zahorska-Markiewicz B
    Przegl Lek; 1987; 44(3):341-4. PubMed ID: 3303155
    [No Abstract]   [Full Text] [Related]  

  • 19. Environmental and genetic determinants of fatty liver in humans.
    Kantartzis K; Schick F; Häring HU; Stefan N
    Dig Dis; 2010; 28(1):169-78. PubMed ID: 20460907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.